American Burn Association
12
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.7%
2 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns
Role: collaborator
The Acute Burn ResUscitation Multicenter Prospective Trial
Role: lead
STAT: Standard Therapy Plus Active Therapy
Role: lead
The Relationship of Rehabilitation Therapy Time To The Prevention of Burn Scar Contracture
Role: lead
A Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn Patients
Role: lead
Rapid Detection of Staphylococcus Aureus in Burn Patients
Role: lead
Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients
Role: lead
Scoring System for Inhalation Injury
Role: lead
The Acute Burn Resuscitation Multicenter Prospective Observational Trial
Role: lead
Effects of a Community Based Exercise Program in Adults With Severe Burns
Role: collaborator
Protective Effects of Propranolol in Adults
Role: collaborator
Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)
Role: lead
All 12 trials loaded